Most medicines have never been adequately tested for safety and efficacy in pediatric populations and preterm, infants and children are particularly vulnerable to adverse drug reactions.<br /><i><br /> Pediatric Drug Development: Concepts and Applications</i>, Second Edition, addresses the unique ch
Pediatric Drug Development
โ Scribed by Andrew E. Mulberg, Lisa L. Mathis, Dianne Murphy, Julia Dunne
- Publisher
- Wiley-Blackwell
- Year
- 2013
- Tongue
- English
- Leaves
- 624
- Edition
- 2
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development.
๐ SIMILAR VOLUMES
This book focuses on the safety efforts being implemented in pediatric drug development. Although children suffer from many of the same diseases as adults and are often treated with the same drugs, only about one-third of the drugs that are prescribed for children have been studied and labeled for p
Most medicines have never been adequately tested for safety and efficacy in pediatric populations and preterm, infants and children are particularly vulnerable to adverse drug reactions. Pediatric Drug Development: Concepts and Applications, Second Edition, addresses the unique challenges in cond
Pediatric Drug Development: Concepts and Applications is designed as a reference and textbook and is meant to address the science of differences between the pediatric and adult subject in the development of pharmaceutical products. Considered are the ethics and medical needs of proper understanding